I agree that this site is using cookies. You can find further informations here.
X
Navarro-Ocón, Alba
23  results:
Search for persons X
?
1

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Ne..:

López-Tejada, Araceli ; Griñán-Lisón, Carmen ; González-González, Adrián...
International Journal of Biological Sciences.  19 (2023)  1 - p. 204-224 , 2023
Link: https://doi.org/10.7150/..
 
?
2

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Navarro-Ocón, Alba ; Blaya-Cánovas, Jose L. ; López-Tejada, Araceli...
Pharmaceutics.  14 (2022)  3 - p. 505 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L. ; López-Tejada, Araceli...
Antioxidants.  10 (2021)  2 - p. 205 , 2021
Link: https://doi.org/10.3390/..
 
?
4

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Ne..:

López-Tejada, Araceli ; Griñán-Lisón, Carmen ; González-González, Adrián...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760438/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Navarro-Ocón, Alba ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
1999-4923.  , 2022
Link: http://hdl.handle.net/10..
 
?
6

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
2076-3921.  , 2021
Link: http://hdl.handle.net/10..
 
?
7

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911462/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Griñan-Lison, Carmen ; Blaya-Cánovas, Jose L ; López-Tejada, Araceli...
https://www.mdpi.com/2076-3921/10/2/205/htm.  , 2021
Link: http://hdl.handle.net/10..
 
?
9

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Alba Navarro-Ocón ; Jose L. Blaya-Cánovas ; Araceli López-Tejada...
Nanomedicine and Nanotechnology.  , 2022
Link: https://doi.org/10.3390/..
 
?
10

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Alba Navarro-Ocón ; Jose L. Blaya-Cánovas ; Araceli López-Tejada...
https://www.mdpi.com/1999-4923/14/3/505.  , 2022
Link: https://doi.org/10.3390/..
 
?
11

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Carmen Griñan-Lison ; Jose L. Blaya-Cánovas ; Araceli López-Tejada...
https://www.mdpi.com/2076-3921/10/2/205.  , 2021
Link: https://doi.org/10.3390/..
 
?
12

Antioxidants for the Treatment of Breast Cancer: Are We The..:

Carmen Griñan-Lison ; Jose L. Blaya-Cánovas ; Araceli López-Tejada...
Health Outcomes of Antioxidants and Oxidative Stress.  , 2021
Link: https://doi.org/10.3390/..
 
?
13

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Ne..:

López Tejada, Araceli ; Griñán Lisón, Carmen ; González González, Adrián...
López-Tejada, A. [et al.] (2023). TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression. International Journal of Biological Sciences, 19(1), 204-224. [https://doi.org/10.7150/ijbs.78738].  , 2023
Link: https://hdl.handle.net/1..
 
?
14

Nanomedicine as a Promising Tool to Overcome Immune Escape ..:

Navarro Ocón, Alba ; Blaya Cánovas, José Lucas ; López Tejada, Araceli...
Navarro-Ocón, A. [et al.]. Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer. Pharmaceutics 2022, 14, 505. [https://doi.org/10.3390/pharmaceutics14030505].  , 2022
Link: http://hdl.handle.net/10..
 
?
15

376 Ovarian remnant syndrome and recurrent ovarian serous c..:

Navarro Campoy, C. ; Morera Ocon, F.
European Journal of Obstetrics & Gynecology and Reproductive Biology.  270 (2022)  - p. e22-23 , 2022
Link: https://doi.org/10.1016/..
 
1-15